Glaucoma
Assessing visual performance in real-world situations is difficult to do in a clinical setting. A recent study in JAMA Ophthalmology, explored the use of virtual reality (VR) in identifying vision-related disability in patients with glaucoma.
In this cross-sectional study, patients with glaucoma (n = 98) and healthy individuals (n = 50) were recruited from a single eye clinic between August 30, 2016 and July 31, 2017.…
featured stories
View Conference Coverage
Take a look at some of our conference coverage, visit our roundup section.
Videos
-
Jan 21, 2020
Does IOP Increase During Scleral Lens Wearing?
-
Jan 15, 2020
Understanding the Link Between Glaucoma and…
-
Jan 15, 2020
Glaucoma Products at AAO
-
Apr 16, 2019
Teleophthalmology for Glaucoma
-
Apr 16, 2019
Patient Education: Detecting Glaucoma Through a…
-
Apr 02, 2019
Tips for Managing Lens-Induced Glaucomas
Conference Roundup
- Dec 21, 2019
Two Glaucoma Treatment Takeaways From AAO 2019
Last winter we reported the latest on important second-line medication treatments for glaucoma…
-
Variation in Prostaglandin Analog Prices Analyzed
Mar 19, 2019
-
Choosing the Right MIGS Procedure
Mar 18, 2019
-
SLT Compared with Medication for IOP Control
Mar 08, 2019
-
Journal Scan
- Mar 24, 2020
Virtual Reality Simulation May Help Patients with Glaucoma
Assessing visual performance in real-world situations is difficult to do in a clinical setting. A recent study in JAMA Ophthalmology, explored the use of virtual reality (VR) in identifying vision-related disability in patients with glaucoma.…
-
-
-
-
Statins May Reduce Glaucoma Risk
Jun 17, 2019
Trending Topics
- Mar 06, 2020
FDA Approves Biodegradable Sustained-release Implant to Lower IOP
The US Food and Drug Administration approved Durysta (bimatoprost implant), the first intracameral, biodegradable sustained-release implant indicated to reduce intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
…
-
-
-
Can Marijuana Effectively Treat Glaucoma?
Aug 07, 2019
-
